BAP1 and neoplasm: Genomic analysis of the clinical tumor and PDX revealed gains in chromosome 1q and chromosome 3, as well as a loss of heterozygosity (LOH) in chromosome 3 involving the 3p21.1 band, which includes the BAP1 gene, in both tumors (Fig. 1C).